Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: Evidence from the MIST2 randomised controlled trial.

The MIST2 trial showed that combined intrapleural use of tissue plasminogen activator (t-PA) and DNase was effective when compared to single agents or placebo. However, the treatment costs are significant and overall cost-effectiveness of combined therapy remains unclear.An economic evaluation of th...

詳細記述

書誌詳細
主要な著者: Luengo-Fernandez, R, Penz, E, Dobson, M, Psallidas, I, Nunn, A, Maskell, N, Rahman, N
フォーマット: Journal article
言語:English
出版事項: European Respiratory Society Publications 2019